EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Beyond Pain: The Effects of OnabotulinumtoxinA Therapy on Sensitization and Interictal Symptoms in Chronic Migraine

Paolo Alonge iD, Filippo Brighina iD, Simona Maccora, Laura Pilati, Salvatore Di Marco, Davide Ventimiglia, Bruna Maggio, Ivana Cutrò, Cecilia Camarda, Angelo Torrente iD

Toxins · 23.04.2024 · 16 (5) · 203

DOI: 10.3390/toxins16050203 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Toxins, online erschienen am 23.04.2024. Verfasst von Paolo Alonge und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.N.D.), University of Palermo, 90127 Palermo, Italy. Hauptthemen laut MEDLINE: Migraine Disorders, Botulinum Toxins, Type A. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic migraine is a disease with a high burden on patients from both a working and quality of life point of view. The pathophysiology of this subtype of migraine is due to several factors, such as medication overuse. Nevertheless, the detrimental recurring of headache attacks with central and peripheral sensitization plays a central role and explains some additional symptoms complained about by these patients even in the interictal phase. OnabotulinumtoxinA is a therapy indicated for chronic migraine since it has proven to reduce peripheral sensitization, showing even efficacy on central symptoms. The aim of this narrative review is to present the current evidence regarding the effect of OnabotulinumtoxinA on sensitization and interictal symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersBotulinum Toxins, Type AHumansChronic Disease

Stichwörter der Autor:innen

central sensitizationchronic migraineinterictal burdeninterictal symptomsmigraineonabotulinumtoxinA

Substanzen

Botulinum Toxins, Type Aonabotulinum toxin A

Autor:innen und Institutionen

  • Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.N.D.), University of Palermo, 90127 Palermo, Italy.
  • Neurology Unit, ARNAS Civico di Cristina and Benfratelli Hospitals, 90127 Palermo, Italy.
  • Neurology and Stroke Unit, P.O. "S. Antonio Abate", 91016 Erice, Italy.

ORCID-Profile: Paolo Alonge, Filippo Brighina, Angelo Torrente

Zitieren

APA

Alonge, P., Brighina, F., Maccora, S., Pilati, L., Di Marco, S., Ventimiglia, D., Maggio, B., Cutrò, I., Camarda, C., & Torrente, A. (2024). Beyond Pain: The Effects of OnabotulinumtoxinA Therapy on Sensitization and Interictal Symptoms in Chronic Migraine. Toxins, 16(5), 203. https://doi.org/10.3390/toxins16050203

Vancouver

Alonge P, Brighina F, Maccora S, Pilati L, Di Marco S, Ventimiglia D, et al. Beyond Pain: The Effects of OnabotulinumtoxinA Therapy on Sensitization and Interictal Symptoms in Chronic Migraine. Toxins. 2024;16(5):203. doi:10.3390/toxins16050203

BibTeX
@article{Alonge2024,
  author = {Alonge, Paolo and Brighina, Filippo and Maccora, Simona and Pilati, Laura and Di Marco, Salvatore and Ventimiglia, Davide and Maggio, Bruna and Cutrò, Ivana and Camarda, Cecilia and Torrente, Angelo},
  title = {Beyond Pain: The Effects of OnabotulinumtoxinA Therapy on Sensitization and Interictal Symptoms in Chronic Migraine},
  journal = {Toxins},
  year = {2024},
  volume = {16},
  number = {5},
  pages = {203},
  doi = {10.3390/toxins16050203}
}
Kostenlos starten →